Join us in Manchester on November 21st 2024 for the Health Tech Conference 2024 – The Tilt Towards Technology: Transforming Greater Manchester Healthcare.   Medtechtomarket will be involved in a number of ways; Firstly, we are a principal sponsor of the event. The main topic for the day is the significant transformation of the Healthcare […]

One of our portable near-patient diagnostic systems that we developed and continue to manufacture is currently being used in emergency clinical trials across multi-centre intensive care units to provide hard data for COVID-19 patient triaging, guiding their therapy, and monitoring stability.

Chloe Tanner, a research associate and MSc student from the University of Birmingham, has joined us to gain valuable lab experience as we continue our work with the University on tetanus and the Monkeypox virus (mpox). Read more about our work on ‘Maximising the impact of vaccines to interrupt Mpox transmission’ here Chloe will be working […]

Medtechtomarket have been working with a local not-for-profit organisation with regulatory and technical support for the production of single-use visors, in our national effort to produce PPE aimed at protecting the frontline NHS staff during the COVID-19 outbreak.

Entegrion’s point-of-care VCM Cascade system for measuring patient haemostasis that was developed, CE marked and still manufactured by Medtechtomarket is being successfully used by a number of the world’s leading authorities in ICU medicine for the therapy monitoring of Covid-19 critically ill patients, as reported in the 31st Annual Elso Conference (Mauro Panigada et al., […]

Study demonstrates utility of Entegrion VCM System for anticoagulation monitoring of Covid-19 patients The VCM test result was used as a daily assessment of the effect of heparin on the viscoelastic properties of 36 critically ill COVID-19 patients. The VCM results were retrospectively compared with laboratory parameters. Anticoagulation was provided with either UFH (52 samples) […]

Outsourcing to an external Contract Development and Manufacturing Organisation (CDMO) for assay development can be a tricky decision to make. Often projects are a labour of love, and a reluctance to collaborate with an external developer can result in delays with bringing medical devices and in vitro diagnostics to market.   Maybe it’s the worry […]

UK Prime Minister, Keir Starmer has announced government plans to reduce hospital waiting lists in England, and tackle the NHS backlog. The waiting list currently stands at 7.5 million, with more than 3 million having already waited longer than the 18-week target. As part of the plan, community diagnostic centres aim to treat patients more quickly, […]

Medtechtomarket Welcomes New Business Development Manager Medtechtomarket is pleased to announce the appointment of Jack Fitzpatrick as Business Development Manager. Hailing from a strong molecular microbiology background, Jack will be instrumental in driving revenue growth and expanding our brand presence by identifying, developing, and bringing in new business opportunities while building on existing partnerships with […]

Medtechtomarket founder, Matt Pearce was invited to contribute to Applied Microbiology International’s ‘The Microbiologist’ magazine for their latest article, “The True Cost of Science”.   The Q & A article by science writer, Hannah Trivett delves into the multifaceted expenses that scientific companies face beyond research and laboratory costs, exploring how these enterprises balance innovation, […]

Medtechtomarket Ltd Achieves ISO 13485 Recertification Medtechtomarket has once again achieved ISO 13485:2016 certification. ISO 13485 is the standard for a Quality Management System (QMS) for the design and manufacture of medical devices. Certification to the standard requires an organisation’s quality management system to pass a third-party Medical Device Single Audit Program, or “MDSAP” Audit. […]

The GlycoScore Prostate Cancer Test, a simple blood test enabling accurate early detection of clinically significant prostate cancer is now entering its clinical trial stage before a potential commercial launch. GlycoScore’s high sensitivity and specificity supports clinical decision-making and the identification of prostate cancer, reducing unnecessary prostate biopsies.   The clinical trials are currently underway […]

AMLo Biosciences Ltd announces the successful receipt of the UKCA mark for AMBLor®, manufactured by Medtechtomarket Ltd. AMBLor – a groundbreaking histopathological biomarker test for the personal identification of early-stage melanomas at low risk of progression, post staging diagnosis – has been awarded the UKCA mark. AMBLor is the first in vitro diagnostic (IVD) of […]

Several Successes to start the year at Medtechtomarket What a start to 2025! At Medtechtomarket we provide a full life-cycle service to develop your medical diagnostics from concept through to commercial launch. Here are examples showcasing the amazing, potentially life-changing projects that we have been working on recently:  FULL PRODUCT LIFE-CYCLE Proteotype diagnostics has devised […]

Maximising the impact of vaccines to interrupt Mpox transmission The recent upsurge of mpox in the Democratic Republic of Congo (DRC) and a growing number of countries in Africa has led to the World Health Organisation (WHO) to declare a public health emergency of international concern (PHEIC) under the International Health Regulations (2005) (IHR). Data […]

What is Mass Spectrometry? Mass Spectrometry (MS) is an analytical technique used to measure the mass-to-charge ratio of ions. The results are presented as a mass spectrum, a plot of intensity as a function of the mass-to-charge ratio. Sometimes referred to as ‘mass-spec’, MS is commonly used in analytical chemistry applications to detect compounds with […]